MedTrace Logo

Testing Methods of Screening for Woman Abuse in Health Care Settings.

NCT00336297 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2006-11-29

No results posted yet for this study

Summary

Recent reviews have identified the need for additional high quality exploratory and evaluative research to understand 1) the actual impact on all women of instituting mass screening procedures versus using indicator-based approaches to identifying woman abuse and 2) the extent to which early identification through screening -- either universal or indicator-based is effective in preventing or ameliorating important outcomes. This is a critical first step in developing a larger randomized controlled trial (RCT) which examines the effectiveness of screening in preventing woman abuse, improving quality of life and other associated outcomes. This study prepares for the RCT by testing the optimal method of administration for the two screening instruments that will be used in the RCT. The administration formats are: computer-based screen, paper and pencil screen and face-to-face screen. They study will also determine recruitment rates.

Conditions

  • Domestic Violence

Interventions

PROCEDURE

Woman Abuse Screening Tool

PROCEDURE

Partner Violence Screen

PROCEDURE

Computerized screening

PROCEDURE

Face to face screening

PROCEDURE

Written screening on forms

Sponsors & Collaborators

  • Ontario Women's Health Council

    collaborator UNKNOWN

  • Hamilton Health Sciences Corporation

    lead OTHER

Principal Investigators

  • Harriet L MacMillan, MD, MSc · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-05-31
Completion
2005-02-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00336297 on ClinicalTrials.gov